199 related articles for article (PubMed ID: 32791559)
1. Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series.
Loughrey MB; McGrath J; Coleman HG; Bankhead P; Maxwell P; McGready C; Bingham V; Humphries MP; Craig SG; McQuaid S; Salto-Tellez M; James JA
Histopathology; 2021 Feb; 78(3):401-413. PubMed ID: 32791559
[TBL] [Abstract][Full Text] [Related]
2. [Comprehensive assessment of mismatch repair and microsatellite instability status in molecular classification of endometrial carcinoma].
Liu Y; Wang YX; Sun XJ; Ting X; Wu R; Liu XD; Liu CR
Zhonghua Fu Chan Ke Za Zhi; 2023 Oct; 58(10):755-765. PubMed ID: 37849256
[No Abstract] [Full Text] [Related]
3. Is tumor testing efficiency for Lynch syndrome different in rectal and colon cancer?
Marabelli M; Gandini S; Rafaniello PR; Calvello M; Tolva G; Feroce I; Lazzeroni M; Marino E; Dal Molin M; Trovato C; Guerrieri-Gonzaga A; Petz WL; Barberis M; Bertario L; Bonanni B
Dig Liver Dis; 2020 Dec; 52(12):1503-1511. PubMed ID: 32620519
[TBL] [Abstract][Full Text] [Related]
4. Novel Biocartis Idylla™ cartridge-based assay for detection of microsatellite instability in colorectal cancer tissues.
Mindiola-RomeroMD AE; GreenBS DC; Al-TurkmaniPhD MR; GodwinBS KN; MackayBS AC; TafeMD LJ; RenMD B; TsongalisPhD GJ
Exp Mol Pathol; 2020 Oct; 116():104519. PubMed ID: 32822722
[TBL] [Abstract][Full Text] [Related]
5. Microsatellite instability in non-endometrioid ovarian epithelial tumors: a study of 400 cases comparing immunohistochemistry, PCR, and NGS based testing with mutation status of MMR genes.
Hájková N; Bártů MK; Cibula D; Drozenová J; Fabian P; Fadare O; Frühauf F; Hausnerová J; Hojný J; Krkavcová E; Laco J; Lax SF; Matěj R; Méhes G; Michálková R; Němejcová K; Singh N; Stolnicu S; Švajdler M; Zima T; McCluggage WG; Stružinská I; Dundr P
Transl Res; 2023 Oct; 260():61-68. PubMed ID: 37244485
[TBL] [Abstract][Full Text] [Related]
6. Discordance of microsatellite instability and mismatch repair immunochemistry occurs depending on the cancer type.
Matsubayashi H; Oishi T; Sasaki K; Abe M; Kiyozumi Y; Higashigawa S; Niiya F; Sato J; Ishiwatari H; Imai K; Hotta K; Kishida Y; Takada K; Ono H; Yamazaki K; Yasui H; Kenmotsu H; Kado N; Kagawa H; Shiomi A; Sugiura T; Bando E; Nishimura S; Hatakeyama K; Serizawa M; Harada R; Sugino T
Hum Pathol; 2023 May; 135():54-64. PubMed ID: 36596344
[TBL] [Abstract][Full Text] [Related]
7. Impact of Pre-Analytical Factors on MSI Test Accuracy in Mucinous Colorectal Adenocarcinoma: A Multi-Assay Concordance Study.
Malapelle U; Parente P; Pepe F; De Luca C; Cerino P; Covelli C; Balestrieri M; Russo G; Bonfitto A; Pisapia P; Fiordelisi F; D'Armiento M; Bruzzese D; Loupakis F; Pietrantonio F; Triassi M; Fassan M; Troncone G; Graziano P
Cells; 2020 Sep; 9(9):. PubMed ID: 32887373
[TBL] [Abstract][Full Text] [Related]
8. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
[TBL] [Abstract][Full Text] [Related]
9. The proportion of endometrial tumours associated with Lynch syndrome (PETALS): A prospective cross-sectional study.
Ryan NAJ; McMahon R; Tobi S; Snowsill T; Esquibel S; Wallace AJ; Bunstone S; Bowers N; Mosneag IE; Kitson SJ; O'Flynn H; Ramchander NC; Sivalingam VN; Frayling IM; Bolton J; McVey RJ; Evans DG; Crosbie EJ
PLoS Med; 2020 Sep; 17(9):e1003263. PubMed ID: 32941469
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of Iranian colorectal cancer patients at risk for Lynch syndrome: a new molecular, clinicopathological feature.
Zeinalian M; Emami MH; Salehi R; Naimi A; Kazemi M; Hashemzadeh-Chaleshtori M
J Gastrointest Cancer; 2015 Jun; 46(2):118-25. PubMed ID: 25722176
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.
Kastrinos F; Steyerberg EW; Balmaña J; Mercado R; Gallinger S; Haile R; Casey G; Hopper JL; LeMarchand L; Lindor NM; Newcomb PA; Thibodeau SN; Syngal S;
Gut; 2013 Feb; 62(2):272-9. PubMed ID: 22345660
[TBL] [Abstract][Full Text] [Related]
12. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
PeerJ; 2023; 11():e15920. PubMed ID: 37663290
[TBL] [Abstract][Full Text] [Related]
13. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H
Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078
[TBL] [Abstract][Full Text] [Related]
14. Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas.
Pino MS; Mino-Kenudson M; Wildemore BM; Ganguly A; Batten J; Sperduti I; Iafrate AJ; Chung DC
J Mol Diagn; 2009 May; 11(3):238-47. PubMed ID: 19324997
[TBL] [Abstract][Full Text] [Related]
15. [Value of detection of DNA mismatch repair proteins deficiency by immunohistochemistry in predicting tumor microsatellite status].
Qin Y; Liang L; Zheng X; Zheng J; Ye J; Guo L; Zhao F; Shi X
Zhonghua Bing Li Xue Za Zhi; 2015 Oct; 44(10):704-8. PubMed ID: 26702526
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers.
Gilson P; Levy J; Rouyer M; Demange J; Husson M; Bonnet C; Salleron J; Leroux A; Merlin JL; Harlé A
Sci Rep; 2020 Oct; 10(1):16386. PubMed ID: 33009475
[TBL] [Abstract][Full Text] [Related]
17. Practical guidance for mismatch repair-deficiency testing in endometrial cancer.
Stelloo E; Jansen AML; Osse EM; Nout RA; Creutzberg CL; Ruano D; Church DN; Morreau H; Smit VTHBM; van Wezel T; Bosse T
Ann Oncol; 2017 Jan; 28(1):96-102. PubMed ID: 27742654
[TBL] [Abstract][Full Text] [Related]
18. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome.
Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM
Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759
[TBL] [Abstract][Full Text] [Related]
19. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
20. Detection of DNA mismatch repair (MMR) deficiencies by immunohistochemistry can effectively diagnose the microsatellite instability (MSI) phenotype in endometrial carcinomas.
McConechy MK; Talhouk A; Li-Chang HH; Leung S; Huntsman DG; Gilks CB; McAlpine JN
Gynecol Oncol; 2015 May; 137(2):306-10. PubMed ID: 25636458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
